Summary

31
Phosphoinositides (PI) are key regulators of cellular organization in eukaryotes and genes 32 that tune PI signalling are implicated in human disease mechanisms. Biochemical analyses 33 and studies in cultured cells have identified a large number of proteins that can mediate PI 34 signalling. However, the role of such proteins in regulating cellular processes in vivo and 35 development in metazoans remains to be understood. Here we describe a set of CRISPR 36 based genome engineering tools that allow the manipulation of each of these proteins with 37 spatial and temporal control during metazoan development. We demonstrate the use of 38 these reagents to deplete a set of 103 proteins individually in the Drosophila eye and identify 39 several new molecules that control eye development. Our work demonstrates the power of 40 Introduction offers a model where one can analyze the control of cellular and developmental processes by 120 PI signalling in a metazoan context. 121
122
In the recent years, CRISPR/Cas9 has emerged as a powerful tool for genome editing in 123 multiple organisms including flies (Gratz et al., 2013; Wang et al., 2016; Wu et al., 2018) . 124
However, unlike transgenic fly lines expressing RNAi constructs that are available against 125 cells for editing prior to biochemical experiments. Considering these points, we decided not 151 to directly use the reference genome sequence to design the gRNAs. The entire genome of 152 S2R+ cells as well as the isogenised parent fly stock (BL# 25709) that was to be used to 153 generate dgRNA transgenic flies were sequenced (Sequencing data is available on 154 hyperlink). Sequences thus obtained were aligned against the reference genome and also 155 against each other. When aligned against the reference genome, both the isogenised parent 156 fly stock and the S2R+ cell genome sequences showed more than 600,000 single nucleotide 157 polymorphisms (SNPs). When compared to each other, these genome sequences had ~1.3 158 million mismatches (SNP, insertions and deletions) suggesting that, as expected, almost all 159 of the sequence differences in the 2 genomes were independent of each other (Figure 2) . 160
While designing the single gRNA (sgRNA), we only chose those targets that did not have 161 sequence mismatches in any of the 3 genomes (reference genome and the 2 genomes 162 sequenced) thus ensuring that the dgRNAs could be used in flies of diverse genetic 163 backgrounds and also in S2R+ cells. In addition, this allowed for a relatively simple way to 164 test the designed dgRNAs in S2R+ cells for their ability to target specific genes prior to 165 generating transgenic fly lines. 166 167 For each gene, two regions were identified wherein a sgRNA would be designed to target 168 each region. The first sgRNA would be designed to target the first coding exon and the 169 second sgRNA to target the exon with the stop codon ( Figure 2) . In case of genes with 170 alternate spliced forms, regions around the most 5' start codon and the most 3' stop codon 171 were chosen (For example, CG3682 has upto 6 splice variants with 4 putative start sites). In 172 cases where two or more putative genes are annotated on the same locus, sgRNA target 173 regions were chosen such that the coding sequences of neighbouring genes are not disrupted 174 (For example, there are 6 different putative ORFs in the first few introns of plc21c and hence 175 the first sgRNA is designed on exon 8). Once a set of two ~100 bp regions were identified 176 for each gene keeping in mind the above-mentioned criteria, we designed the sgRNAs using 177 an online tool (http://targetfinder.flycrispr.neuro.brown.edu) with zero predicted off-178 targets. During the course of this study, an additional online tool 179 (https://www.flyrnai.org/evaluateCrispr/) became available. Thereafter, this tool was used 180 to obtain a predicted efficiency score. The most efficient sgRNAs in the region were then checked in our sequence database for presence of any mismatches in either S2R+ cells or 182 injection fly stocks compared to the reference genome sequence. The best sgRNA sequences 183 predicted to efficiently target specific genes with no predicted off-targets and absence of any 184 mismatches were chosen for synthesis. Any sgRNA sequences that did not qualify these 185 criteria were discarded and new sgRNAs designed to fit all of the above criteria. 186 187
Generation of gRNA expression constructs 188
The first sgRNAs targeting the start codon for each gene were cloned into the pBFv6.2 vector 189 and the second sgRNAs targeting the stop codon into the pBFv6.2B vector. Both of these 190 vectors ubiquitously express the gRNAs under the U6.2 promoter (Kondo and Ueda, 2013) . 191
The two sgRNA constructs targeting a given gene along with pUAST-Cas9-T2A-eGFP were 192 co-transfected into S2R+ cells stably expressing Tubulin-Gal4 (Gift from Satyajit Mayor). 193
The sgRNA pairs that led to the deletion of the gene, as tested by PCR and sequencing of the 194 target gene loci, were chosen for dual-gRNA (dgRNA) construction. In case a particular pair 195 of sgRNAs failed to delete the target gene, a new set of sgRNAs were designed for both the 196 first and the last coding exon and different combinations of sgRNAs were tested until the 197 most optimal pair capable of deleting the target gene was identified. 198
199
Once a functional pair of sgRNAs capable of deleting a target gene was identified, the first 200 sgRNA was cloned into the pBFv6.2B vector containing the second sgRNA to generate the 201 dgRNA construct (U6-dgRNA). These constructs were then microinjected to generate 202 dgRNA transgenic flies for each of the 103 PI signalling genes ( Figure 2 ). This U6-dgRNA 203 construct can also be transfected in S2R+ cells to generate gene deletions for cell culture-204 based experiments. For genes that are present on the 2 nd chromosome, the dgRNA construct 205 was inserted on the 3 rd chromosome (Table I ). For all the other genes, the dgRNA was 206 inserted on the 2 nd chromosome (See materials and methods). This design offers the 207 advantage that when used to generate whole fly knockouts, the dgRNA transgenes can 208 subsequently be readily out-crossed given that the gRNA and the target gene are on two 209 different chromosomes. 210 211 212
Generation of UAS-Cas9-eGFP transgenic lines 213
At the core of CRISPR/Cas9 technology is the endonuclease Cas9 which utilizes gRNAs to 214 target specific genomic sequences and generate a double stranded break. Transgenic flies 215
expressing Cas9 under UAS control are already available (Port et al., 2019). However, these 216 lack a reporter and therefore it is difficult to readily identify cells or tissues expressing Cas9, 217 which would be of great advantage when targeting genes in a tissue specific manner. In order 218 to satisfy this requirement, we designed and generated transgenic UAS-Cas9 flies with a 219 fluorescence reporter eGFP. Given that the human codon optimised Cas9 (Cas9.P2) 220 expresses at lower levels thereby reducing the cytotoxic effects of the otherwise highly 221 expressing Cas9.C (Meltzer et al., 2019) , we have used Cas9.P2 to generate our construct. In 222 order to ensure that the presence of an eGFP tag does not hinder the activity of Cas9, we 223 introduced a self-cleaving peptide T2A sequence in between Cas9 and eGFP ( Figure 3A) . 224
This ensured that while the Cas9 and eGFP are expressed from the same mRNA, they are 225 made as two independent proteins. Presence of the eGFP coding sequence downstream of 226
Cas9 ensured that every cell positive for eGFP fluorescence would definitely also express 227
Cas9. In addition, we tagged the Cas9 with a nuclear localization signal (NLS) at both the 228 N-and the C-terminal to facilitate its translocation into the nucleus for better access of the 229 genomic DNA. 230
231
The UAS-Cas9-T2A-eGFP construct thus generated was tested for its genome editing 232 efficiency and the usefulness of eGFP as a reporter. To test the Cas9, the pUAST-Cas9-T2A-233 eGFP construct was transfected along with the dgRNA against CG5734 (a gene predicted to 234 have a PH domain that may bind to PI3P) into S2R+ cells constitutively expressing Tubulin-235
Gal4. As a control, the cells were parallelly co-transfected with the pBS-hsp70-Cas9 plasmid 236 (Addgene Plasmid #46294) and the dual-gRNA against CG5734. Forty-eight hours post 237 transfection the cells were harvested. Half the cells were used for protein extraction and 238
Western blotting. Western blotting showed that Cas9 was being expressed from the UAS-239
Cas9-T2A-eGFP construct. The molecular size of Cas9 from this construct was similar to 240
Cas9 expressed from pBS-hsp70-Cas9. Detection of a band corresponding to the molecular 241 weight of free eGFP in cells transfected with UAS-Cas9-T2A-eGFP suggest that the T2A 242 sequence was working efficiently to generate Cas9 and eGFP as two independent proteins from a single mRNA ( Figure 3B ). From the other half of the cells, genomic DNA was isolated 244 and PCR performed to detect deletions in CG5734. We found the predicted deletion 245 fragment generated by both the Cas9 from the newly generated pUAST-Cas9-T2A-eGFP 246 plasmid and the Cas9 expressed from the pBS-hsp70-Cas9 control plasmid ( Figure 3C ) thus 247 verifying that Cas9 expressed from the pUAST-Cas9-T2A-eGFP construct was capable of 248 deleting target genes in the presence of appropriate gRNAs. 249
250
After verification in S2R+ cells, the pUAST-Cas9-T2A-eGFP construct was microinjected 251 into fly embryos along with a helper plasmid expressing transposase to facilitate random P-252 element based insertion and obtain transgenic flies. In order to verify that the fly line 253 obtained expresses Cas9, we crossed these lines to salivary gland specific Gal4 (AB1Gal4) 254 flies. The progeny flies were dissected, salivary glands stained for Cas9 and imaged. All 255 salivary gland cells expressed eGFP and were also stained positive for Cas9 thus 256 demonstrating that the pUAST-Cas9-T2A-eGFP construct can be used as expected to drive 257
Cas9 expression and to mark the Cas9 expressing cells with eGFP ( Figure 3D ). The eGFP 258 expression was predominantly nuclear although some cytosolic expression could be 259 observed. Cas9 did not have the same intracellular localization thus suggesting that the T2A 260 sequence was functional and that the two proteins, Cas9 and eGFP were being expressed as To test the use of our dgRNA transgenic library, we studied the effect of deletion of PI 281 signalling genes in the eye disc during development by expressing Cas9-T2A-eGFP using 282 eyeless-Gal4 (eyGal4). eyeless (ey) is expressed very early on in the eye primordia in the 283 embryo and before the formation of the morphogenetic furrow at the time of photoreceptor 284 determination in the third instar larva (Halder et al., 1995) . In addition, ey is also expressed 285 in neurons. To delete target genes in a tissue specific manner we generated ey-Gal4; UAS-286
Cas9-T2A-eGFP flies and crossed them individually to each of the 103 U6-dgRNA transgenic 287 lines. Prior to analysing the phenotypes obtained in the progeny of these crosses, we tested 288 whether the gene under study was being edited in a tissue specific manner. For this, we 289 isolated genomic DNA from the head and the body of a few representative ey>GAL4; UAS-290
Cas9-T2A-eGFP; U6-dgRNA flies and performed a PCR to detect the expected genomic 291 deletion. Expected genomic deletions were identified in DNA obtained from fly heads but 292 not in DNA obtained from the fly body suggesting tissue (eye) specific gene deletion using 293 our newly generated reagents ( Figure 4A ). Further, this suggested that the UAS-Cas9-T2A-294 eGFP was indeed under the control of eyGal4 and had minimal or no influence from other 295 genetic elements despite being generated by random P-element insertion. 296
297
The eyes of progeny flies from each of the crosses between ey-Gal4; UAS-Cas9-T2A-eGFP 298 and the 103 U6-dgRNA transgenic lines were imaged with appropriate controls. A spectrum 299 of phenotypes was obtained ranging from smaller eyes as in the case of Dp110 [ Figure 4B Table I . 308
309
Deletion of Class I PI3K (Dp110), that converts PI(4,5)P2 to PI(3,4,5)P3 resulted in smaller 310 eyes compared to controls. This is in agreement with a number of studies that have 311 dgRNA mediated PI3K knockout showed a stronger phenotype with eyes ~75% smaller 318
[ Figure 5B (ii) and C] than appropriate controls [ Figure 5B (i)] thus demonstrating that 319 these dgRNAs serve as efficient tools to study tissue specific roles of genes. 320 321
Targeting multiple genes using dgRNAs to study genetic interaction in specific tissues 322
Understanding genetic interactions is an important approach to establish the molecular 323 pathways underpinning any given biological process. In order to demonstrate that the 324 dgRNA library can be used to target multiple genes simultaneously in a tissue specific 325 manner, we took advantage of the reversible nature of the PIP2 to PIP3 conversion by 326 5A (iv) and C). However, the eyes of this double mutant flies were smaller compared to 334 control flies possibly because the Dp110 dgRNA was more efficient than the Pten dgRNA 335 resulting in a greater reduction of PIP3 levels.
The fact that multiple genes can be targeted simultaneously in a tissue specific manner using 338 CRISPR/Cas9 technology is of great advantage. Traditionally, genetic interactions have been 339 studied by generation of double mutants through meiotic recombination. However, this 340 may not be a viable option in many cases wherein the genes being studied lead to organismal 341 lethality when disrupted or when the genetic loci of the two genes being studied are very 342 close thereby drastically reducing the recombination efficiency between these genes. In fact, 343 several genes involved in the PI signalling cascade are clustered together on different 344 chromosomes. Our dgRNA transgenic fly library offers an opportunity to generate tissue 345 specific double knockouts independent of the proximity of these genes. In order to rule out the possibility that the rdgB U6-dgRNA was non-functional in 353 developing eye discs, we crossed the same rdgB U6-dgRNA transgenic flies to nanos-Cas9 to 354 generate a complete germline knockout of rdgB ( Figure 6A ). ERG recordings from this 355 germline knockout of rdgB generated using CRISPR/Cas9 was comparable to rdgB 2 (Figure  356 6B), an amorphic allele generated by chemical mutagenesis in the Benzer lab (Harris and 357 Stark, 1977) . In a similar manner, using the U6-dgRNA transgenic flies, we generated 358 germline knockouts of several additional genes by crossing them to either nanos, vasa or 359
Act5c-Cas9 flies (Table I) . Several gRNAs when crossed to Act5c-Cas9 or vasa-Cas9 flies 360 showed pupal lethality and hence were then crossed to nanos-Cas9 flies. The deletions 361 obtained in this manner are highly efficient (between 4-100% efficiency in F1 flies and 362 between 3-70% efficiency in F2 flies) in generating germline knockouts with deletions 363 ranging in size between 400bp and 38kb. For a few genes, we were unable to generate 364 germline deletions despite repeated attempts possibly due to their essential roles in 365 gametogenesis or embryogenesis. 366
Anomalous behaviour of the Cas9 deletion system 368
We crossed the rdgB U6-dgRNA flies with ey-Gal4;UAS-Cas9-T2A-eGFP flies. The progeny 369 were collected and their ERG recorded. In contrast to the rdgB 2 allele and the germline rdgB 370 knockout generated in this study (see previous section), we observed no reduction in ERG 371 amplitude compared to wild-type flies ( Figure 6D ). Although PCR analysis of these eyes 372 confirmed the occurrence of deletion events, Western blot analysis from heads of rdgB U6-373 dgRNA, ey-Gal4;UAS-Cas9-T2A-eGFP flies revealed that the RDGB protein was still present 374 in these eyes ( Figure 6C ) thus explaining the normal ERG amplitude observed. This finding 375 implies that although rdgB U6-dgRNA worked efficiently to generate germline deletions, it 376 was not effective in tissue specific depletion of RDGB protein levels. The reasons for this are 377 not entirely clear. We speculate that RDGB is a protein with a long half-life and therefore 378 despite efficient targeting of rdgB locus by the dgRNA in the eyes, the protein levels are not 379 affected. However, it is also possible that the deletion of rdgB was not homogeneous in all 380 eye precursor cells where Cas9 was expressed using ey-Gal4; residual photoreceptors with 381 normal rdgB might be sufficient to generate a normal light response. 382 383 skittles (sktl) is a PI4P 5-kinase known to have a role during larval development (Hassan et  384 al., 1998). Mutations in sktl are organismal lethal as well as cell lethal. Hence, we expected 385 a strong phenotype when the sktl locus was deleted in eye discs using ey-Gal4. However, 386 when U6-sgRNA or U6-dgRNA targeting sktl was used, we did not see any morphological 387
Discussion
Patterning tissue architecture during metazoan development or the systemic control of 400 animal physiology are complex processes and typically involves the function of genes acting 401 in both cell-autonomous and non-cell autonomous modes. Identifying novel genes 402 regulating these processes and uncovering their mode of action is facilitated by the ability to 403 inactivate genes in specific cell types, tissue domains or organs with spatial and temporal 404 precision. Such controlled inactivation can be achieved through the use of gene 405 manipulation systems expressed with spatial and temporal precision using the GAL4/UAS 406 system (Brand and Perrimon, 1993) and this approach has been coupled previously with 407 methods to deplete specific RNAs to study their role in development and physiology (Reim 408 et al., 2014) . In this study, we present the use of the GAL4/UAS module for gene inactivation 409 by using the CRISPR/Cas9 gene editing system. By expressing Cas9 with spatial and 410 temporal precision using the GAL4/UAS system we were able to selectively inactivate genes 411 in early precursor cells of the eye imaginal disc and thus uncover functions of the PI 412 signalling system in the growth and patterning of the Drosophila eye. Using this method, we 413 uncovered the function of 30 PI signalling genes in eye development and 9 genes previously 414 not implicated in this process. Using our system, we identified phenotypes for genes such as 415
Dp110 and Pten that are previously described using either classical mutant alleles or using 416
RNAi mediated depletion. However, the tool kit presented here includes reagents for editing 417 ca. 72 PI binding proteins. While these have been described by in vitro protein biochemistry 418 studies or predicted from structural bioinformatics, their function in vivo and their role in During the course of this study, we identified a few limitations for the use of these reagents. 481
For example, in the case of the PI4P 5-kinase sktl, eye specific deletion resulted in 482 morphologically normal looking eyes. The reason for this was most likely that cells lacking 483 sktl were eliminated (due to the essential nature of the gene product) early in eye disc 484 development and only those cells with indels that are multiples of three bases thus possibly 485 producing a partially functional protein survived. This is however dependent on the nature 486 of the gene rather than the design of the gRNA constructs. For example, when sgRNA 487 targeting the kinase domain of sktl was used in conjunction with ey>UAS-Cas9-GFP, flies 488 were pupal lethal presumably because even 1-2 bp deletions within the kinase domain of sktl were able to detect the presence of full-length protein in flies when eye specific knockout 491 was performed. The possibility that either of the gRNAs were inefficient or non-functional 492
in tissues was ruled out as we were able to use the rdgB U6-dgRNA flies to generate a germ 493 line knockout of this gene that phenocopied existing classical alleles. Since rdgB is located 494 on the X-chromosome the inability to lose the protein by tissue specific editing is unlikely 495 to be due to editing of only one copy of the gene. We therefore speculate that the residual 496 protein in eye specific editing of rdgB most likely results from the long half-life of the protein 497 that was present from early development. The implications of this is that when used for 498 performing a screen in a tissue specific manner, the lack of a phenotype does not 499 conclusively rule out the involvement of that gene. Apart from the two examples described 500 here, it is possible that CRISPR based targeting of genes in a tissue specific manner may lead 501 to heterogeneous disruption of the target gene especially in polyploid larval tissues such as 502 the salivary glands and fat body. Therefore, absence of phenotypes in these tissue specific 503 gene disruptions using dgRNA will not be conclusive and under these circumstances 504 generation of a germ line knock out would be valuable. 505
506
In summary, we have generated a toolkit consisting of a transgenic library of 103 dgRNA 507 and a pUAST-Cas9-T2A-eGFP that can be used in conjunction with the existing large 508 repertoire of GAL4 lines to perform a systems level analysis of PI signalling selectively in 509 any cell type/tissue of choice. The pUAST-Cas9-T2A-eGFP construct would be helpful to 510 track Cas9 expressing cells in culture or in fly tissues. The U6-dgRNAs can also be 511 transfected to delete gene function in cultured Drosophila cells. They can also be used to 512 generate whole body knockouts and the null alleles so generated can be used as a template 513 to knock in specific versions of the gene at the endogenous locus. While the PI kinases and 514 phosphatases have been the subject of extensive analysis, the effectors of PI signalling, 515 namely the binding proteins remain poorly studied. We envisage the availability of this 516 dgRNA reagent set will accelerate the studies of the function of these proteins in cellular 517 organization and tissue architecture. They will also facilitate the functional analysis of 518 disease mechanisms in the case of those proteins linked to human disease. 519 Dietzl, G., Chen, D., Schnorrer, F., Su, K.C., Barinova, Y., Fellner, M., Gasser, B., Kinsey, K., and verified using the CRISPR Efficiency Prediction Tool (DRSC). The first gRNA (gRNA 1; indicated in blue) was designed to target the first coding exon and the second gRNA (gRNA 2; indicated in green) was designed to target the last coding exon. It was ensured that these designed gRNAs did not have any mismatches when compared against any of the 3 genomes (the genomes of Drosophila BL25709 line used for microinjection, S2R+ cells and the reference genome). The two gRNAs (gRNA 1 and gRNA 2) for each gene were cloned into pBFv6.2 and pBFv6.2B respectively and tested in S2R+ cells for their ability to delete the target genes in the presence of Cas9.
Following this, both the gRNAs for each gene were cloned into a single plasmid to generate the dgRNA constructs. These were microinjected into Drosophila embryos to generate dgRNA transgenic flies against each of the PI-signalling genes. 
